Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating chronic urticaria

A technology of chronic urticaria and composition, which is applied in the field of pharmaceutical composition for the treatment of chronic urticaria, and can solve the problems of repeated attacks and high recurrence rate of chronic urticaria

Inactive Publication Date: 2015-04-22
宋妍
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, chronic urticaria often shows recurrent attacks, which is protracted and difficult to heal, which brings great pain to patients.
There are many ways to treat chronic urticaria. Western medicine generally uses antihistamines and glucocorticoids. Although the symptoms can be temporarily controlled, the recurrence rate is high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0015] Selected 80 patients with chronic urticaria, including 34 males and 46 females; aged 19-62 years, with an average of 38 years; the course of the disease ranged from 8 weeks to 3 years, with an average of 5.6 months. All patients were >14 years old, with transient wheal and pruritus as the main clinical symptoms, and the course of disease was ≥4 weeks, and there were wheals when they visited the doctor. Those who have one of the following conditions are not eligible for selection: ①Patients with severe arrhythmia and structural heart disease; ②Oral or injected glucocorticoids or other antihistamines in the last 2 weeks; ③Patients with severe liver and kidney disease Functional insufficiency; ④ age <14 years old; ⑤ pregnant and lactating women.

[0016] Use the lotion prepared in the embodiment to treat, 3 times a day, use gauze to dip in 200 ml of lotion each time, and then cover it on the skin wheal and itching for 5 minutes. Continuous treatment for 20 days.

[0017]...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for treating chronic urticaria. The pharmaceutical composition is prepared from the following medicinal raw materials in parts by weight: 150-200 parts of garden balsam herb, 100-150 parts of lithospermum arvense, 130-180 parts of hemistepta lyrata, 100-150 parts of glechoma longituba, 130-190 parts of pampanin shuteria herb, 100-150 parts of semen allii tuberose, 100-150 parts of sassafras, 100-150 parts of caulis spatholobi, 50-100 parts of bile arisaema, 50-100 parts of raspberries, 50-100 parts of fructus aurantii, 100-150 parts of funaria hygrometrica, 50-100 parts of polygonum cuspidatum, 150-200 parts of bauhinia championii, 130-170 parts of heliotropium indicum, 100-150 parts of wolfberry fruits, 150-200 parts of ipomoea pes-caprae, 80-130 parts of longans, 100-150 parts of lepisori herba, 80-120 parts of garden balsam stems, 50-80 parts of storax, 30-70 parts of spina gleditsiae, 100-150 parts of ainsliaefolious cacalia roots and 100-150 parts of liquorice. The pharmaceutical composition for treating chronic urticaria provided by the invention is reasonable in formula and has the characteristics of exact in curative effect, safe and convenient, free of toxic and side effects and low in cost.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition for treating chronic urticaria. Background technique [0002] Urticaria is a kind of allergic skin disease, is called " rubella group " by people. Clinically, there are often acute and chronic urticaria, and the general course of disease is considered to be chronic urticaria if it exceeds 8 weeks. And chronic urticaria often shows effect repeatedly, protracted and difficult to heal, brings huge misery to the patient. There are many ways to treat chronic urticaria. Western medicine generally adopts antihistamines and glucocorticoids. Although they can temporarily control symptoms, the recurrence rate is high. Contents of the invention [0003] The purpose of the present invention is to provide a pharmaceutical composition for treating chronic urticaria. [0004] In order to realize the object of the present invention, the present invention provides a kind ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8962A61P17/00
Inventor 宋妍曹忠琛
Owner 宋妍
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com